240 related articles for article (PubMed ID: 16563760)
1. The search for novel TRPV1-antagonists: from carboxamides to benzimidazoles and indazolones.
Fletcher SR; McIver E; Lewis S; Burkamp F; Leech C; Mason G; Boyce S; Morrison D; Richards G; Sutton K; Jones AB
Bioorg Med Chem Lett; 2006 Jun; 16(11):2872-6. PubMed ID: 16563760
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationship (SAR) investigations of substituted imidazole analogs as TRPV1 antagonists.
Gore VK; Ma VV; Tamir R; Gavva NR; Treanor JJ; Norman MH
Bioorg Med Chem Lett; 2007 Nov; 17(21):5825-30. PubMed ID: 17851073
[TBL] [Abstract][Full Text] [Related]
3. 4-(2-Pyridyl)piperazine-1-benzimidazoles as potent TRPV1 antagonists.
Shao B; Huang J; Sun Q; Valenzano KJ; Schmid L; Nolan S
Bioorg Med Chem Lett; 2005 Feb; 15(3):719-23. PubMed ID: 15664844
[TBL] [Abstract][Full Text] [Related]
4. Design of potent, orally available antagonists of the transient receptor potential vanilloid 1. Structure-activity relationships of 2-piperazin-1-yl-1H-benzimidazoles.
Ognyanov VI; Balan C; Bannon AW; Bo Y; Dominguez C; Fotsch C; Gore VK; Klionsky L; Ma VV; Qian YX; Tamir R; Wang X; Xi N; Xu S; Zhu D; Gavva NR; Treanor JJ; Norman MH
J Med Chem; 2006 Jun; 49(12):3719-42. PubMed ID: 16759115
[TBL] [Abstract][Full Text] [Related]
5. N-Tetrahydroquinolinyl, N-quinolinyl and N-isoquinolinyl biaryl carboxamides as antagonists of TRPV1.
Westaway SM; Chung YK; Davis JB; Holland V; Jerman JC; Medhurst SJ; Rami HK; Stemp G; Stevens AJ; Thompson M; Winborn KY; Wright J
Bioorg Med Chem Lett; 2006 Sep; 16(17):4533-6. PubMed ID: 16806913
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of thiazole carboxamides as vanilloid receptor 1 (TRPV1) antagonists.
Xi N; Bo Y; Doherty EM; Fotsch C; Gavva NR; Han N; Hungate RW; Klionsky L; Liu Q; Tamir R; Xu S; Treanor JJ; Norman MH
Bioorg Med Chem Lett; 2005 Dec; 15(23):5211-7. PubMed ID: 16203144
[TBL] [Abstract][Full Text] [Related]
7. Benzimidazole-substituted (3-phenoxypropyl)amines as histamine H3 receptor ligands.
Aslanian R; Zhu X; Vaccaro HA; Shih NY; Piwinski JJ; Williams SM; West RE
Bioorg Med Chem Lett; 2008 Sep; 18(18):5032-6. PubMed ID: 18752952
[TBL] [Abstract][Full Text] [Related]
8. Discovery of piperidine carboxamide TRPV1 antagonists.
Cheung WS; Calvo RR; Tounge BA; Zhang SP; Stone DR; Brandt MR; Hutchinson T; Flores CM; Player MR
Bioorg Med Chem Lett; 2008 Aug; 18(16):4569-72. PubMed ID: 18662879
[TBL] [Abstract][Full Text] [Related]
9. Heteroaryl beta-tetralin ureas as novel antagonists of human TRPV1.
Jetter MC; Youngman MA; McNally JJ; McDonnell ME; Zhang SP; Dubin AE; Nasser N; Codd EE; Flores CM; Dax SL
Bioorg Med Chem Lett; 2007 Nov; 17(22):6160-3. PubMed ID: 17892935
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and biological evaluation of novel diarylalkyl amides as TRPV1 antagonists.
Li FN; Kim NJ; Paek SM; Kwon DY; Min KH; Jeong YS; Kim SY; Park YH; Kim HD; Park HG; Suh YG
Bioorg Med Chem; 2009 May; 17(10):3557-67. PubMed ID: 19398205
[TBL] [Abstract][Full Text] [Related]
11. Benzimidazole-2-carboxamides as novel NR2B selective NMDA receptor antagonists.
Borza I; Kolok S; Gere A; Nagy J; Fodor L; Galgóczy K; Fetter J; Bertha F; Agai B; Horváth C; Farkas S; Domány G
Bioorg Med Chem Lett; 2006 Sep; 16(17):4638-40. PubMed ID: 16782335
[TBL] [Abstract][Full Text] [Related]
12. Design, syntheses, and structure-activity relationships of novel NPY Y5 receptor antagonists: 2-{3-Oxospiro[isobenzofuran-1(3H),4'-piperidin]-1'-yl}benzimidazole derivatives.
Ogino Y; Ohtake N; Nagae Y; Matsuda K; Moriya M; Suga T; Ishikawa M; Kanesaka M; Mitobe Y; Ito J; Kanno T; Ishihara A; Iwaasa H; Ohe T; Kanatani A; Fukami T
Bioorg Med Chem Lett; 2008 Sep; 18(18):5010-4. PubMed ID: 18723347
[TBL] [Abstract][Full Text] [Related]
13. Substituted aryl pyrimidines as potent and soluble TRPV1 antagonists.
Stec MM; Bo Y; Chakrabarti PP; Liao L; Ncube M; Tamayo N; Tamir R; Gavva NR; Treanor JJ; Norman MH
Bioorg Med Chem Lett; 2008 Sep; 18(18):5118-22. PubMed ID: 18722118
[TBL] [Abstract][Full Text] [Related]
14. Discovery of potent, soluble and orally active TRPV1 antagonists. Structure-activity relationships of a series of isoxazoles.
Ratcliffe P; Abernethy L; Ansari N; Cameron K; Clarkson T; Dempster M; Dunn D; Easson AM; Edwards D; Everett K; Feilden H; Ho KK; Kultgen S; Littlewood P; Maclean J; McArthur D; McGregor D; McLuskey H; Neagu I; Nimz O; Nisbet LA; Ohlmeyer M; Palin R; Pham Q; Rong Y; Roughton A; Sammons M; Swanson R; Tracey H; Walker G
Bioorg Med Chem Lett; 2011 Aug; 21(15):4652-7. PubMed ID: 21723725
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity studies of a novel series of 5,6-fused heteroaromatic ureas as TRPV1 antagonists.
Drizin I; Gomtsyan A; Bayburt EK; Schmidt RG; Zheng GZ; Perner RJ; DiDomenico S; Koenig JR; Turner SC; Jinkerson TK; Brown BS; Keddy RG; McDonald HA; Honore P; Wismer CT; Marsh KC; Wetter JM; Polakowski JS; Segreti JA; Jarvis MF; Faltynek CR; Lee CH
Bioorg Med Chem; 2006 Jul; 14(14):4740-9. PubMed ID: 16621571
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of 5-substituted and 4,5-disubstituted-2-arylamino oxazole TRPV1 antagonists.
Perner RJ; Koenig JR; Didomenico S; Gomtsyan A; Schmidt RG; Lee CH; Hsu MC; McDonald HA; Gauvin DM; Joshi S; Turner TM; Reilly RM; Kym PR; Kort ME
Bioorg Med Chem; 2010 Jul; 18(13):4821-9. PubMed ID: 20570528
[TBL] [Abstract][Full Text] [Related]
17. Novel antiprotozoal products: imidazole and benzimidazole N-oxide derivatives and related compounds.
Aguirre G; Boiani M; Cerecetto H; Gerpe A; González M; Sainz YF; Denicola A; De Ocáriz CO; Nogal JJ; Montero D; Escario JA
Arch Pharm (Weinheim); 2004 May; 337(5):259-70. PubMed ID: 15095419
[TBL] [Abstract][Full Text] [Related]
18. Identification of potent, soluble, and orally active TRPV1 antagonists.
Ratcliffe P; Maclean J; Abernethy L; Clarkson T; Dempster M; Easson AM; Edwards D; Everett K; Feilden H; Littlewood P; McArthur D; McGregor D; McLuskey H; Nimz O; Nisbet LA; Palin R; Tracey H; Walker G
Bioorg Med Chem Lett; 2011 Apr; 21(8):2559-63. PubMed ID: 21435873
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity studies of a novel series of isoxazole-3-carboxamide derivatives as TRPV1 antagonists.
Palin R; Abernethy L; Ansari N; Cameron K; Clarkson T; Dempster M; Dunn D; Easson AM; Edwards D; Maclean J; Everett K; Feilden H; Ho KK; Kultgen S; Littlewood P; McArthur D; McGregor D; McLuskey H; Neagu I; Neale S; Nisbet LA; Ohlmeyer M; Pham Q; Ratcliffe P; Rong Y; Roughton A; Sammons M; Swanson R; Tracey H; Walker G
Bioorg Med Chem Lett; 2011 Feb; 21(3):892-8. PubMed ID: 21236666
[TBL] [Abstract][Full Text] [Related]
20. TRPing the switch on pain: an introduction to the chemistry and biology of capsaicin and TRPV1.
Conway SJ
Chem Soc Rev; 2008 Aug; 37(8):1530-45. PubMed ID: 18648679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
